SUNPHARMA - Swing Trade Analysis with AI Signals
← Back to ListKey Parameters
⭐ Swing Trade Rating: 4.2
Show all parameters (20 more)
🧾 Trade Setup
Entry Price: 1805 ₹. Target Exit Level 1875₹ – A stop-loss order can be placed at 1800₹, aiming for a profit target of around 1875₹ within the next 3-5 days based on the current momentum and RSI signal. This represents a relatively conservative swing trade with manageable risk given the strong earnings performance. Overall, SUNPHARMA presents a compelling opportunity for short to medium-term gains but requires diligent monitoring for any sign of reversal.
✅ Positive
The recent PAT growth of 22.8% and a substantial increase in quarterly profits (1,139 Cr vs 609 Cr) demonstrate significant near-term momentum. Furthermore, the RSI reading of 37.2 indicates the stock is currently undervalued relative to its historical levels and suggests potential for an upward price correction.
⚠️ Limitation
Despite strong recent earnings, the Stock P/E ratio of 138 remains exceptionally high compared to the industry average of 34.8, indicating a premium valuation which presents a considerable risk if momentum fades. The substantial debt-to-equity ratio of 0.61 also warrants attention as it could constrain future growth opportunities and potentially impact shareholder returns.
🏭 Industry
The pharmaceutical sector is currently experiencing moderate bullish sentiment driven by innovation in drug development and regulatory approvals, though concerns regarding generic drug pricing pressures remain a persistent factor for many players; recent gains in Taro Pharmaceutical’s stock price due to the merger offer provide further tailwinds.